Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Novocure Ltd Ord Sh (NVCR)

Novocure Ltd Ord Sh (NVCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Novocure Ltd Ord Sh NO. 4 THE FORUM GRENVILLE STREET ST. HELIER Y9 JE2 4UF JEY

www.novocure.com P: 44-0-15-3475-6700

Description:

NovoCure Limited is an oncology company. The Company is engaged in developing a therapy called Tumor Treating Fields for the treatment of solid tumor cancers. It operates primarily in the United States, Germany, Switzerland and Japan. NovoCure Limited is based in Saint Helier, Channel Islands.

Key Statistics

Overview:

Market Capitalization, $K 2,385,736
Enterprise Value, $K 2,711,996
Shares Outstanding, K 107,611
Annual Sales, $ 509,340 K
Annual Net Income, $ -207,040 K
Last Quarter Sales, $ 138,500 K
Last Quarter Net Income, $ -38,760 K
EBIT, $ -214,150 K
EBITDA, $ -226,270 K
60-Month Beta 0.50
% of Insider Shareholders 6.29%
% of Institutional Shareholders 84.61%
Float, K 100,842
% Float 93.71%
Short Volume Ratio 0.34

Growth:

1-Year Return -71.97%
3-Year Return -87.84%
5-Year Return -58.44%
5-Year Revenue Growth 105.32%
5-Year Earnings Growth -182.61%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.36 on 05/02/24
Latest Earnings Date N/A
Earnings Per Share ttm -1.81
EPS Growth vs. Prev Qtr 20.00%
EPS Growth vs. Prev Year 28.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

NVCR Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -50.35%
Return-on-Assets % -16.86%
Profit Margin % -40.65%
Debt/Equity 1.59
Price/Sales 4.45
Price/Cash Flow N/A
Price/Book 6.08
Book Value/Share 3.34
Interest Coverage -5.66
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar